IL29 抗体 (AA 20-200)
-
- 抗原 See all IL29 抗体
- IL29 (Interleukin 29 (IL29))
-
抗原表位
- AA 20-200
-
适用
- 人
-
宿主
- 兔
-
克隆类型
- 多克隆
-
标记
- This IL29 antibody is un-conjugated
-
应用范围
- ELISA, Immunohistochemistry (IHC)
- 交叉反应
- 人
- 纯化方法
- Antigen Affinity Purified
- 免疫原
- Recombinant Human Interferon lambda-1 protein (20-200AA)
- 亚型
- IgG
- Top Product
- Discover our top product IL29 Primary Antibody
-
-
- 应用备注
- Recommended dilution: IHC:1:20-1:200,
- 限制
- 仅限研究用
-
- 状态
- Liquid
- 缓冲液
- PBS with 0.02 % sodium azide, 50 % glycerol, pH 7.3.
- 储存液
- Sodium azide
- 注意事项
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- 储存条件
- -20 °C,-80 °C
- 储存方法
- Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
- 抗原
- IL29 (Interleukin 29 (IL29))
- 别名
- IFNL1 (IL29 产品)
- 别名
- IL-29 antibody, IL29 antibody, interferon lambda 1 antibody, interferon lambda-1 antibody, interleukin 29 (interferon, lambda 1) antibody, IFNL1 antibody, LOC612539 antibody, IL29 antibody
- 背景
-
Background: Cytokine with antiviral, antitumour and immunomodulatory activities. Plays a critical role in the antiviral host defense, predominantly in the epithelial tissues. Acts as a ligand for the heterodimeric class II cytokine receptor composed of IL10RB and IFNLR1, and receptor engagement leads to the activation of the JAK/STAT signaling pathway resulting in the expression of IFN-stimulated genes (ISG), which mediate the antiviral state. Has a restricted receptor distribution and therefore restricted targets: is primarily active in epithelial cells and this cell type-selective action is because of the epithelial cell-specific expression of its receptor IFNLR1. Exerts an immunomodulatory effect by up-regulating MHC class I antigen expression.
Aliases: IFNL1 antibody, IL29 antibody, ZCYTO21Interferon lambda-1 antibody, IFN-lambda-1 antibody, Cytokine Zcyto21 antibody, Interleukin-29 antibody, IL-29 antibody
- UniProt
- Q8IU54
-